Market Research Report

Recombinant Human Serum Albumin Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-14234
  • CAT ID : 7
  • Pages : 114
  • Date : Jun 2023
 

The global Recombinant Human Serum Albumin market was valued at US$ 77 million in 2022 and is projected to reach US$ 123.4 million by 2029, at a CAGR of 7.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of recombinant human serum albumin (Recombinant Human Serum Albumin) include Albumedix, Merck and Ventria (InVitria). The top three manufacturers account for about 88% of the global share. North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively. North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively. In terms of product type, ScrHSA is the largest segment, holding about 91% share. In terms of application, cell culture media is the largest downstream segment with about 73% share; followed by medical supplements.
Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Serum Albumin. This report contains market size and forecasts of Recombinant Human Serum Albumin in global, including the following market information:
Global Recombinant Human Serum Albumin Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Human Serum Albumin Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Recombinant Human Serum Albumin companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Human Serum Albumin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Serum Albumin Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Recombinant Human Serum Albumin Market Segment Percentages, by Type, 2022 (%)
OsrHSA
ScrHSA
Global Recombinant Human Serum Albumin Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Recombinant Human Serum Albumin Market Segment Percentages, by Application, 2022 (%)
Cell Culture Media
Medical Supplements
Other
Global Recombinant Human Serum Albumin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Recombinant Human Serum Albumin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Serum Albumin revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Human Serum Albumin revenues share in global market, 2022 (%)
Key companies Recombinant Human Serum Albumin sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Recombinant Human Serum Albumin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Human Serum Albumin, market overview.
Chapter 2: Global Recombinant Human Serum Albumin market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Human Serum Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Human Serum Albumin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Serum Albumin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Human Serum Albumin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Serum Albumin Overall Market Size
2.1 Global Recombinant Human Serum Albumin Market Size: 2022 VS 2029
2.2 Global Recombinant Human Serum Albumin Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Human Serum Albumin Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Human Serum Albumin Players in Global Market
3.2 Top Global Recombinant Human Serum Albumin Companies Ranked by Revenue
3.3 Global Recombinant Human Serum Albumin Revenue by Companies
3.4 Global Recombinant Human Serum Albumin Sales by Companies
3.5 Global Recombinant Human Serum Albumin Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Human Serum Albumin Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Human Serum Albumin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Human Serum Albumin Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Human Serum Albumin Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Serum Albumin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Human Serum Albumin Market Size Markets, 2022 & 2029
4.1.2 OsrHSA
4.1.3 ScrHSA
4.2 By Type - Global Recombinant Human Serum Albumin Revenue & Forecasts
4.2.1 By Type - Global Recombinant Human Serum Albumin Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Human Serum Albumin Revenue, 2024-2029
4.2.3 By Type - Global Recombinant Human Serum Albumin Revenue Market Share, 2018-2029
4.3 By Type - Global Recombinant Human Serum Albumin Sales & Forecasts
4.3.1 By Type - Global Recombinant Human Serum Albumin Sales, 2018-2023
4.3.2 By Type - Global Recombinant Human Serum Albumin Sales, 2024-2029
4.3.3 By Type - Global Recombinant Human Serum Albumin Sales Market Share, 2018-2029
4.4 By Type - Global Recombinant Human Serum Albumin Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Human Serum Albumin Market Size, 2022 & 2029
5.1.2 Cell Culture Media
5.1.3 Medical Supplements
5.1.4 Other
5.2 By Application - Global Recombinant Human Serum Albumin Revenue & Forecasts
5.2.1 By Application - Global Recombinant Human Serum Albumin Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Human Serum Albumin Revenue, 2024-2029
5.2.3 By Application - Global Recombinant Human Serum Albumin Revenue Market Share, 2018-2029
5.3 By Application - Global Recombinant Human Serum Albumin Sales & Forecasts
5.3.1 By Application - Global Recombinant Human Serum Albumin Sales, 2018-2023
5.3.2 By Application - Global Recombinant Human Serum Albumin Sales, 2024-2029
5.3.3 By Application - Global Recombinant Human Serum Albumin Sales Market Share, 2018-2029
5.4 By Application - Global Recombinant Human Serum Albumin Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Recombinant Human Serum Albumin Market Size, 2022 & 2029
6.2 By Region - Global Recombinant Human Serum Albumin Revenue & Forecasts
6.2.1 By Region - Global Recombinant Human Serum Albumin Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Human Serum Albumin Revenue, 2024-2029
6.2.3 By Region - Global Recombinant Human Serum Albumin Revenue Market Share, 2018-2029
6.3 By Region - Global Recombinant Human Serum Albumin Sales & Forecasts
6.3.1 By Region - Global Recombinant Human Serum Albumin Sales, 2018-2023
6.3.2 By Region - Global Recombinant Human Serum Albumin Sales, 2024-2029
6.3.3 By Region - Global Recombinant Human Serum Albumin Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Recombinant Human Serum Albumin Revenue, 2018-2029
6.4.2 By Country - North America Recombinant Human Serum Albumin Sales, 2018-2029
6.4.3 US Recombinant Human Serum Albumin Market Size, 2018-2029
6.4.4 Canada Recombinant Human Serum Albumin Market Size, 2018-2029
6.4.5 Mexico Recombinant Human Serum Albumin Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Recombinant Human Serum Albumin Revenue, 2018-2029
6.5.2 By Country - Europe Recombinant Human Serum Albumin Sales, 2018-2029
6.5.3 Germany Recombinant Human Serum Albumin Market Size, 2018-2029
6.5.4 France Recombinant Human Serum Albumin Market Size, 2018-2029
6.5.5 U.K. Recombinant Human Serum Albumin Market Size, 2018-2029
6.5.6 Italy Recombinant Human Serum Albumin Market Size, 2018-2029
6.5.7 Russia Recombinant Human Serum Albumin Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Human Serum Albumin Market Size, 2018-2029
6.5.9 Benelux Recombinant Human Serum Albumin Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Recombinant Human Serum Albumin Revenue, 2018-2029
6.6.2 By Region - Asia Recombinant Human Serum Albumin Sales, 2018-2029
6.6.3 China Recombinant Human Serum Albumin Market Size, 2018-2029
6.6.4 Japan Recombinant Human Serum Albumin Market Size, 2018-2029
6.6.5 South Korea Recombinant Human Serum Albumin Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Human Serum Albumin Market Size, 2018-2029
6.6.7 India Recombinant Human Serum Albumin Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Recombinant Human Serum Albumin Revenue, 2018-2029
6.7.2 By Country - South America Recombinant Human Serum Albumin Sales, 2018-2029
6.7.3 Brazil Recombinant Human Serum Albumin Market Size, 2018-2029
6.7.4 Argentina Recombinant Human Serum Albumin Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Human Serum Albumin Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Recombinant Human Serum Albumin Sales, 2018-2029
6.8.3 Turkey Recombinant Human Serum Albumin Market Size, 2018-2029
6.8.4 Israel Recombinant Human Serum Albumin Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Human Serum Albumin Market Size, 2018-2029
6.8.6 UAE Recombinant Human Serum Albumin Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Albumedix
7.1.1 Albumedix Company Summary
7.1.2 Albumedix Business Overview
7.1.3 Albumedix Recombinant Human Serum Albumin Major Product Offerings
7.1.4 Albumedix Recombinant Human Serum Albumin Sales and Revenue in Global (2018-2023)
7.1.5 Albumedix Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Recombinant Human Serum Albumin Major Product Offerings
7.2.4 Merck Recombinant Human Serum Albumin Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Ventria (InVitria)
7.3.1 Ventria (InVitria) Company Summary
7.3.2 Ventria (InVitria) Business Overview
7.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Major Product Offerings
7.3.4 Ventria (InVitria) Recombinant Human Serum Albumin Sales and Revenue in Global (2018-2023)
7.3.5 Ventria (InVitria) Key News & Latest Developments
7.4 NCPC
7.4.1 NCPC Company Summary
7.4.2 NCPC Business Overview
7.4.3 NCPC Recombinant Human Serum Albumin Major Product Offerings
7.4.4 NCPC Recombinant Human Serum Albumin Sales and Revenue in Global (2018-2023)
7.4.5 NCPC Key News & Latest Developments
7.5 Oryzogen
7.5.1 Oryzogen Company Summary
7.5.2 Oryzogen Business Overview
7.5.3 Oryzogen Recombinant Human Serum Albumin Major Product Offerings
7.5.4 Oryzogen Recombinant Human Serum Albumin Sales and Revenue in Global (2018-2023)
7.5.5 Oryzogen Key News & Latest Developments
7.6 HiMedia
7.6.1 HiMedia Company Summary
7.6.2 HiMedia Business Overview
7.6.3 HiMedia Recombinant Human Serum Albumin Major Product Offerings
7.6.4 HiMedia Recombinant Human Serum Albumin Sales and Revenue in Global (2018-2023)
7.6.5 HiMedia Key News & Latest Developments
8 Global Recombinant Human Serum Albumin Production Capacity, Analysis
8.1 Global Recombinant Human Serum Albumin Production Capacity, 2018-2029
8.2 Recombinant Human Serum Albumin Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Serum Albumin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Human Serum Albumin Supply Chain Analysis
10.1 Recombinant Human Serum Albumin Industry Value Chain
10.2 Recombinant Human Serum Albumin Upstream Market
10.3 Recombinant Human Serum Albumin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Human Serum Albumin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe